Alzheimer's Account Liaison
Posted on: 2 Dec 2021
Houston, TX
Job Description
Job Description
· Establish Access: Engage with health care systems, sites of care and health care professionals involved in Neurology and Alzheimer’s disease care to understand the challenges in identified integrated health systems, sites of care, hospitals, academic centers and Alzheimer’s Disease Centers of Excellence.
· Profile Accounts: Understand the Alzheimer’s disease ecosystem, market dynamics, account infrastructure, and account perspectives on diagnosis and management of Alzheimer’s disease. Understand the priorities, protocols, and patient flow for accounts/sites of care.
· Develop Account Plans: Using knowledge of the healthcare market, evolving trends in care and Alzheimer’s disease patient treatment model, create and maintain account plans with tailored strategic objectives and action plans.
· Collaboration & communication with cross functional partners: Lead and participate on cross functional business teams to represent customers and field perspectives in strategic planning. Continually coordinate and align strategies, action plans, and communication approaches. Share customer and market insights, perceptions and trends to appropriate Biogen partners to inform and support commercial strategy.
Qualifications
· Bachelor’s Degree; alternatively, comparable years of additional, related experience will be considered
· 6+ years of progressive, broad commercial experience, including strong strategic account management experience
· Experience supporting buy & bill / medical benefit products
· Exemplary collaborative ability in a heavily-matrixed environment
· Exemplary ability to synthesize a complex, nebulous market environment and create plans of action
· Exemplary ability to deal with ambiguity, be resourceful and problem solve
· Exemplary ability of resilience and agility
· Experience and comfort interacting with C-Suite leadership
· One [or several] of the following key experiences are desirable, but not required:
o Alzheimer’s [symptomatic/diagnostic] or related neuroscience experience
o Launch experience, ideally in area of unmet healthcare needs
o Experience with co-promotion
Biogen
Cambridge, MA
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; and IMRALDI, an adalimumab biosimilar referencing HUMIRA. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies.
Further, it is involved in developing BIIB098, Opicinumab, and BIIB061 for MS and neuroimmunology; Aducanumab, Elenbecestat, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB092 and BIIB054 for treating Parkinson's disease and movement disorders; BIIB067, BIIB078, and BIIB110 to treat neuromuscular disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB104 for treating neurocognitive disorders; BIIB074 and BIIB095 for pain; and Dapirolzumab pegol, BG00011, and BIIB059 for treating other diseases, which are under various stages of development.
The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc., Eisai Co., Ltd., Alkermes Pharma Ireland Limited, Bristol-Myers Squibb Company, Acorda Therapeutics, Inc., AbbVie Inc., C4 Therapeutics, University of Pennsylvania, Applied Genetic Technologies Corporation, and others. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
-
IndustryBiotechnology
-
No. of Employees7,800
-
Website
-
Jobs Posted445
